John M. Siebert, Ph.D.
DirectoratSupernus Pharmaceuticals· In proxies 2023–2024
John M. Siebert, Ph.D. sits on 2 public boards.
Experience
- Supernus PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +12%
- Partner of Riverside PharmaceuticalsPublic company
- Director? – PresentNo stock prices for these years
- Riverside PharmaceuticalsPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?